Wednesday, October 1, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Needham Analyst Reiterates Buy Rating and 28 Price Target for Liquidia Technologies

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Trading online
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Needham analyst Serge Belanger has reiterated his Buy rating and $28 price target for Liquidia (NASDAQ:LQDA) on March 13, 2024. This reaffirmation underscores his optimistic view on the company’s future performance and growth opportunities. Belanger’s analysis is in line with the overall market sentiment, showcasing a strong belief in Liquidia Technologies amid favorable market conditions and regulatory environment. The ongoing endorsement from Needham signifies a continued confidence in the company’s potential, as echoed by various analyst perspectives.

LQDA Stock Shows Strong Performance with 5.36% Increase on March 13, 2024

On March 13, 2024, LQDA stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of LQDA shares increased by $0.75 since the market last closed, representing a 5.36% rise. The stock closed at $14.73, showing a significant increase in value. Additionally, in after-hours trading, the stock rose by an additional $0.21. Investors and analysts may view these price movements as a sign of strength in the stock, as it continues to show growth and potential for further gains. It is important for investors to conduct thorough research and analysis before making any investment decisions.

LQDA Stock Analysis: Revenue Flat, Net Income Improves – March 13, 2024

On March 13, 2024, LQDA stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for LQDA stood at $15.94 million for the past year, which remained flat compared to the previous year. However, there was a significant decrease of 23.15% in total revenue since the last quarter, with the company reporting $3.68 million in revenue for Q3.

The net income for LQDA was reported at -$41.02 million for the past year, showing a decrease of 18.61% compared to the previous year. However, there was a positive sign as the net income improved by 32.86% since the last quarter, with a reported net income of -$15.79 million for Q3.

Earnings per share (EPS) for LQDA were reported at -$0.67 for the past year, showing a slight increase of 3.35% compared to the previous year. The EPS also saw a significant improvement of 32.92% since the last quarter, with a reported EPS of -$0.24 for Q3.

Tags: LQDA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biopharmaceutical Stock Market Today (1)

Title Poseida Therapeutics Receives Orphan Drug Designation for PBCMAALLO1 Targeting Multiple Myeloma

From Stress Relief to Sleep Improvement: Unveiling the Latest Innovations in Vagus Nerve Stimulation Devices

Cue Health NASDAQ HLTH Q4 Earnings Report Key Highlights

Automotive Trading online

Vroom Inc Q4 Financial Results Impact Stock Performance and Future Outlook

Recommended

Motorola Stock

Motorola Solutions Strengthens Defense Technology Position Through Strategic Acquisitions

3 weeks ago
Honeywell Stock

Honeywell Faces Legal Challenge Following Air India Crash

1 week ago
Healthcare Services Stock Exchange

HCA Healthcare Reports Impressive Fourth Quarter Earnings and Sales Growth

2 years ago
IonQ Stock

Quantum Computing Stock Slips Despite Strategic Board Appointment

14 hours ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Gold Reaches Unprecedented Highs Amid US Political Turmoil

Leadership Purchases Signal Strong Confidence in Deutz AG

Thyssenkrupp’s Strategic Gamble: Can a Naval Powerhouse Rescue the Parent Company?

Sudden CFO Departure Sends Redcare Pharmacy Shares Tumbling

Idorsia Shares Surge on Heavy Trading Volume

Deutsche Telekom Launches Major Share Buyback Initiative

Trending

Valneva Stock
Analysis

Valneva Shares Surge on Breakthrough Vaccine Data

by Andreas Sommer
October 1, 2025
0

Investors are celebrating a major turnaround for Valneva as the biopharmaceutical company released compelling long-term results for...

Covestro Stock

Covestro Shares Surge as ADNOC Acquisition Nears Approval

October 1, 2025
Novo Nordisk Stock

Pharmaceutical Giant Faces Mounting Challenges as Analyst Turns Bearish

October 1, 2025
Gold Stock

Gold Reaches Unprecedented Highs Amid US Political Turmoil

October 1, 2025
Deutz AG Stock

Leadership Purchases Signal Strong Confidence in Deutz AG

October 1, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Valneva Shares Surge on Breakthrough Vaccine Data
  • Covestro Shares Surge as ADNOC Acquisition Nears Approval
  • Pharmaceutical Giant Faces Mounting Challenges as Analyst Turns Bearish

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com